Skip to main content
Premium Trial:

Request an Annual Quote

As Planned, Sequenom Implements Reverse Stock Split in Effort to Regain Nasdaq Compliance

NEW YORK, June 2 (GenomeWeb News) - Sequenom today implemented a planned 1-for-3 reverse stock split in an effort to regain compliance with the Nasdaq exchange.


Under the split, each three outstanding shares of common stock are automatically combined and converted into one share. Since fractional shares will not be issued, cash payments will be made for those shares.


As GenomeWeb News reported on Wednesday, Sequenom's shareholders approved the split, and to increase the authorized shares of its common stock to 185 million.


The reverse split is part of the company's plan to regain compliance with Nasdaq National Market listing requirements. Sequenom last week received a letter saying it was not in compliance. Nasdaq Listing Qualifications Panel will decide whether to grant the company's request to continue being listed.


For the next 20 days, the company's Nasdaq ticker symbol will be SQNMD. The ticker symbol will return to the regular SQNM after this period.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.